Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50K | Oct 2, 2024 | Direct | ||
Axcella Health Inc. | Director | Stock Option (Right to Buy) | 40K | Nov 16, 2022 | Direct | ||
Evelo Biosciences, Inc. | Director | Stock Option (Right to Buy) | 30K | Jun 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Oct 2, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Director |
OMGA | Omega Therapeutics, Inc. | Oct 2, 2024 | 0 | $0 | 3 | Oct 4, 2024 | Director |
EVLO | Evelo Biosciences, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
EVLO | Evelo Biosciences, Inc. | Apr 14, 2023 | 1 | $0 | 4 | Apr 18, 2023 | Director |
EVLO | Evelo Biosciences, Inc. | Apr 14, 2023 | 0 | $0 | 3 | Apr 18, 2023 | Director |
AXLA | Axcella Health Inc. | Nov 16, 2022 | 1 | $0 | 4 | Nov 18, 2022 | Director |
AXLA | Axcella Health Inc. | Oct 10, 2022 | 0 | $0 | 3 | Oct 17, 2022 | Director |